GlassScriptPhysician profile
Brent E Vanhoozen
NPI 1093757445
$9,600.85
in general payments reported to CMS, 2019-2025
45 companies · $1,189 in 2025
The $1,189 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,561 · 2020: $1,155 · 2021: $1,263 · 2022: $1,168 · 2023: $1,311 · 2024: $1,953 · 2025: $1,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,124 · Education: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,124.35 |
| Education | $328.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,115.35 | 2021-2025 | Avycaz, Teflaro, Dalvance |
| Glaxosmithkline, LLC. | $1,007.89 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $949.53 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Allergan, INC. | $843.63 | 2019-2020 | |
| Astellas Pharma US INC | $720.70 | 2019-2025 | Ambisome, Cresemba |
| Boehringer Ingelheim Pharmaceuticals, INC. | $578.25 | 2019-2024 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Viiv Healthcare Company | $432.41 | 2023-2025 | Dovato, Cabenuva, Rukobia |
| Gilead Sciences, INC. | $392.02 | 2021-2025 | |
| Inari Medical, INC. | $218.32 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| United Therapeutics Corporation | $215.32 | 2019-2025 | Tyvaso, Orenitram, Tyvaso |
| Verona Pharma, INC. | $190.60 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $160.74 | 2019-2025 | Zerbaxa, Delstrigo, Pifeltro |
| Genentech USA, INC. | $157.27 | 2019-2020 | |
| Intuitive Surgical, INC. | $152.54 | 2022 | |
| Amgen INC. | $130.50 | 2022-2024 | Tezspire |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $117.37 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Grifols USA, LLC | $109.03 | 2019-2024 | Prolastin-C Liquid |
| Advanced Respiratory, INC | $88.50 | 2019-2021 | |
| Harmony Biosciences LLC | $76.30 | 2020-2025 | |
| Electromed, INC. | $69.26 | 2019-2024 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $68.39 | 2022-2023 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $64.20 | 2020 | |
| Shire North American Group INC | $60.33 | 2019 | |
| Portola Pharmaceuticals, LLC | $60.15 | 2019 | |
| Resmed Corp | $60.00 | 2019 | |
| Philips North America LLC | $53.12 | 2023-2024 | (Ak6) Vest Therapy |
| Janssen Biotech, INC. | $47.94 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $46.69 | 2019 | |
| Shionogi INC | $39.05 | 2022-2025 | Fetroja |
| Mylan Specialty L.P. | $36.49 | 2019 | |
| Pulmonx Corporation | $35.28 | 2020-2024 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Theratechnologies INC. | $34.51 | 2023 | Egrifta, Trogarzo |
| Covis Pharma Gmbh | $29.94 | 2022 | |
| Genzyme Corporation | $29.70 | 2024 | |
| Insmed, INC. | $28.82 | 2023 | Arikayce |
| Avadel Cns Pharmaceuticals, LLC | $27.10 | 2025 | Lumryz |
| Sanofi-Aventis U.S. LLC | $23.90 | 2019 | |
| Greer Laboratories, INC. | $18.86 | 2019 | |
| Mallinckrodt Hospital Products INC. | $18.58 | 2025 | Acthar |
| Paratek Pharmaceuticals, INC. | $17.92 | 2025 | Nuzyra |
| La Jolla Pharmaceutical Company | $17.65 | 2019 | |
| Viatris Specialty LLC | $14.86 | 2025 | Yupelri |
| Pfizer INC. | $14.68 | 2024 | |
| Emd Serono, INC. | $14.41 | 2023 | Serostim |
| Hartmann USA, INC. | $12.75 | 2023 | Zetuvit Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Vanhoozen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.